Asian Hospital and Healthcare management offers the most advanced strategies in healthcare, the most significant developments in hospital management, provides information on the latest research in healthcare and medical sciences with a special focus on preventive medicine and healthcare.
MILAN Oct 3 2016 PRNewswire Edwards Lifesciences Corporation NYSE EW the global leader in patientfocused innovations for structural heart disease and critical care monitoring today announced it received CE Mark for its Acumen Hypotension Probability Indicator HPI a breakthrough technology that al..
SEATTLE Oct 3 2016 PRNewswire CTI BioPharma Corp CTI BioPharma NASDAQ and MTACTIC today announced that James A Bianco MD CTI BioPharmas President and Chief Executive Officer has retired from the Company effective on October 2nd At the request of the Board of Directors Richard Love a director of CT..
DUBLIN Oct 3 2016 PRNewswire Allergan plc NYSE AGN today announced that it has entered into a licensing agreement with MedImmune AstraZenecas global biologics research and development arm for the global rights to MEDI2070 MEDI2070 is an antiIL23 monoclonal antibody currently in Phase IIb clinical ..
ZURICH and EINDHOVEN The Netherlands October 3 2016 PRNewswire Three childrens hearts are now beating with a Xeltis Valve Laurent Grandidier CEO Xeltis Click here for video about how the Xeltis restoring technology works ZURICH Switzerland and EINDHOVEN The Netherlands October 3 2016 Xeltis ..
DUBLIN October 3 2016 PRNewswire Carrick Therapeutics Ltd a unique new venture in cancer treatment launched today having secured 95M in funding It brings together worldclass cancer researchers and drug development experts backed by some of the most eminent providers of early stage capital with t..
NEW HAVEN Conn Oct 3 2016 PRNewswire Biohaven Pharmaceutical Holding Company Ltd Biohaven or the Company today announced it has acquired the rights from Rutgers The State University of New Jersey to develop and commercialize certain glutamate modulating agents in the treatment of cancer Research..
GENEVA October 3 2016 PRNewswire A new Roadmap to tackle NonValvular Atrial Fibrillation AF the most common and clinically significant form of cardiac arrhythmia has been launched today by the World Heart Federation WHF The initiative aims to help prevent AF and to improve its management worldw..
PITTSBURGH Oct 1 2016 PRNewswire UPMC for Life the Medicare Advantage product of UPMC Health Plan remains committed in 2017 to offering high quality plans at premium costs that are among the lowest in 28 counties in the Western Pennsylvania region UPMC for Life is offering six plans in 2017 f..
PITTSBURGH Oct 1 2016 PRNewswire UPMC for Life the Medicare Advantage product of UPMC Health Plan will now offer high quality and high value plans in Philadelphia County for 2017 UPMC for Life is offering three HMO plans so that that Medicareeligible members can choose the one that best suits th..
PITTSBURGH Oct 1 2016 PRNewswire UPMC for Life the Medicare Advantage product of UPMC Health Plan is offering high quality plans at premium costs that are among the lowest in five counties in the Lehigh Capital Pennsylvania region UPMC for Life is offering three HMO plans in 2017 in Lancaster C..
EAST HANOVER NJ Oct 1 2016 PRNewswire Novartis announced today new data showing Cosentyx secukinumab delivers efficacy in patients with moderate to severe plaque psoriasis out to four years of treatment These latebreaking data come from the extension study of the Phase III SCULPTURE trial1 Results..
TARRYTOWN NY and PARIS Oct 1 2016 PRNewswire Regeneron Pharmaceuticals Inc NASDAQ REGN and Sanofi today announce that detailed results from LIBERTY AD SOLO 1 and SOLO 2 two placebocontrolled Phase 3 studies evaluating investigational Dupixent dupilumab in adult patients with inadequately controll..
VIENNA Oct 1 2016 PRNewswire Janssen Research Development LLC Janssen announced today findings from the first of three pivotal Phase 3 studies evaluating guselkumab a subcutaneously administered antiinterleukin IL23 monoclonal antibody in latestage development for the treatment of adults wi..
MUMBAI India and PRINCETON NJ Oct 1 2016 PRNewswire Sun Pharma Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE 524715 Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies through its wholly owned subsidiary today will announce latebreaking data from two pivotal ..
MURFREESBORO Tenn Sept 30 2016 PRNewswire National HealthCare CorporationNYSE MKT NHC the nations oldest publicly traded senior health care company today announced that both Donald K Daniel and Charlotte A Swafford have informed the Board of Directors that they plan to retire from their positions ..
WASHINGTON Sept 30 2016 PRNewswire Paralyzed Veterans of America Paralyzed Veterans is proud to announce that it will be honored with the Hope Award for Advocacy by nonprofit organization RESOLVE The award is given to an individual or organization whose work has raised public awareness advanced a ..
SOUTH SAN FRANCISCO Calif Sept 30 2016 PRNewswire Veracyte IncNASDAQ VCYT a genomic diagnostics company focused on reducing diagnostic uncertainty today issued the statement below on the Centers for Medicare and Medicaid Services CMS final 2017 gapfill Medicare reimbursement rate for the Afirma Ge..
RIDGEFIELD Conn Sept 28 2016 PRNewswire Boehringer Ingelheim and ViraTherapeutics today announced a longterm collaboration to jointly develop a next generation oncolytic virus therapy platform and to investigate ViraTherapeutics lead candidate VSVGP Vesicular Stomatitis Virus VSV glycoprotein GP a..
WHIPPANY NJ Sept28 2016 PRNewswire Bayer announced today that the latest research across its growing oncology portfolio will be presented at the European Society of Medical Oncology ESMO 2016 Congress taking place on October 711 in Copenhagen Denmark The data span a variety of difficulttotreat can..
GAITHERSBURG Md Sept 28 2016 PRNewswire GenVec Inc NASDAQ GNVC a clinicalstage gene delivery company announced that Douglas E Brough PhD the companys chief scientific officer will present Exploring the AdenoVerse Platform for New Advanced Cell and Gene Therapiesa brief review of GenVecs technology..